GlassScriptPhysician profile
Patrick John Pham
NPI 1184078149
$10,601.78
in general payments reported to CMS, 2019-2025
25 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $157 · 2021: $450 · 2022: $1,254 · 2023: $6,599 · 2024: $722 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,394 · Food and Beverage: $2,710 · Gift: $50.31 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,393.84 |
| Food and Beverage | $2,709.51 |
| Gift | $50.31 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $5,948.77 | 2022-2024 | Lumera 700, Visumax |
| Alcon Vision LLC | $1,184.94 | 2019-2025 | Clareon, Tryptyr, Argos |
| Bausch & Lomb Americas INC. | $705.06 | 2022-2025 | Envista Mx60 Iol, Sofport Ao, Amvisc |
| Glaukos Corporation | $318.42 | 2021-2022 | |
| Dompe US, INC. | $281.55 | 2024-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $245.49 | 2025 | Tecnis Iol |
| Abbvie INC. | $227.51 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $191.16 | 2021-2025 | |
| Carl Zeiss Meditec, INC. | $184.44 | 2022 | |
| Ocular Therapeutix, INC. | $149.65 | 2025 | Dextenza |
| Allergan, INC. | $147.51 | 2022 | |
| Harrow Eye, LLC | $141.46 | 2023 | Iheezo |
| Oyster Point Pharma, INC. | $140.66 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $131.40 | 2021 | |
| Omeros Corporation | $117.63 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $115.01 | 2020 | |
| Rxsight INC | $102.72 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| New World Medical,INC. | $102.35 | 2022 | |
| Beaver-Visitec International, INC. | $39.56 | 2023 | |
| Ivantis, INC | $26.88 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.13 | 2023 | |
| Kala Pharmaceuticals, INC. | $22.37 | 2022 | |
| Sight Sciences, INC. | $21.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.52 | 2022 | |
| Alimera Sciences, INC. | $15.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.